Trial Profile
Phase Ib combination trial of AEG 40826 in cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 24 Dec 2012
Price :
$35
*
At a glance
- Drugs AEG 40826 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 24 Dec 2012 New trial record